Staar Surgical Insider Files Form 144 for Minor $47K Share Sale

Rhea-AI Filing Summary

Staar Surgical Co. (STAA) filed a Form 144 indicating a proposed sale of 1,750 common shares through broker Merrill Lynch, 520 Newport Center Dr., Newport Beach, CA. The shares represent a negligible fraction (≈0.004%) of the 49,526,129 shares outstanding. The filer values the block at $47,025.13 and plans to execute the sale on or about 08/05/2025 on the Nasdaq.

The securities were originally acquired 03/14/2024 via an open-market purchase and paid for in cash on 03/18/2024. No sales by the same beneficial owner occurred during the previous three months, and the filer attests to possessing no undisclosed material adverse information about the company.

Given the small size relative to total float and lack of additional context (e.g., identity or role of the seller), the filing signals routine liquidity management rather than a materially significant insider move.

Insights

Equity Analyst

TL;DR: Minor insider sale (1,750 shares) equals ~0.004% of float—unlikely to affect STAA valuation.

The Form 144 discloses intent to sell 1,750 STAA shares worth roughly $47k. Relative to the 49.5 million shares outstanding, the transaction is immaterial and does not suggest strategic shifts or insider sentiment changes. No pattern of recent selling is reported, and the filer affirms no undisclosed adverse information. For portfolio managers, the notice is non-impactful; trading liquidity and price discovery should remain unaffected.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 520 Newport Center Drive Floor 20 Newport Beach CA 92660	1750	47025.13	49526129	08/05/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/14/2024	Open Market Purchase	N/A			1750	03/18/2024	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Staar Surgical (STAA) shares are being sold in this Form 144 filing?

The notice covers 1,750 common shares.

What is the aggregate market value of the STAA shares to be sold?

The filer lists an aggregate value of $47,025.13.

When is the proposed sale date for the STAA shares?

The sale is expected to occur on or about 08/05/2025.

What percentage of Staar Surgical's outstanding shares does this sale represent?

Approximately 0.004% of the 49,526,129 shares outstanding.

Was there any prior selling activity by the filer in the past three months?

No. The Form 144 states "Nothing to Report" for prior three-month sales.